BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 18443294)

  • 1. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.
    Purhonen S; Palm J; Rossi D; Kaskenpää N; Rajantie I; Ylä-Herttuala S; Alitalo K; Weissman IL; Salven P
    Proc Natl Acad Sci U S A; 2008 May; 105(18):6620-5. PubMed ID: 18443294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors.
    Wickersheim A; Kerber M; de Miguel LS; Plate KH; Machein MR
    Int J Cancer; 2009 Oct; 125(8):1771-7. PubMed ID: 19582874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROCK suppression promotes differentiation and expansion of endothelial cells from embryonic stem cell-derived Flk1(+) mesodermal precursor cells.
    Joo HJ; Choi DK; Lim JS; Park JS; Lee SH; Song S; Shin JH; Lim DS; Kim I; Hwang KC; Koh GY
    Blood; 2012 Sep; 120(13):2733-44. PubMed ID: 22896004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.
    Real C; Remédio L; Caiado F; Igreja C; Borges C; Trindade A; Pinto-do-Ó P; Yagita H; Duarte A; Dias S
    PLoS One; 2011 Apr; 6(4):e18323. PubMed ID: 21483741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo.
    Murayama T; Tepper OM; Silver M; Ma H; Losordo DW; Isner JM; Asahara T; Kalka C
    Exp Hematol; 2002 Aug; 30(8):967-72. PubMed ID: 12160849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells.
    Rajantie I; Ilmonen M; Alminaite A; Ozerdem U; Alitalo K; Salven P
    Blood; 2004 Oct; 104(7):2084-6. PubMed ID: 15191949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.
    Reddy K; Zhou Z; Jia SF; Lee TH; Morales-Arias J; Cao Y; Kleinerman ES
    Int J Cancer; 2008 Aug; 123(4):831-7. PubMed ID: 18537159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma.
    Ria R; Vacca A; Russo F; Cirulli T; Massaia M; Tosi P; Cavo M; Guidolin D; Ribatti D; Dammacco F
    Thromb Haemost; 2004 Dec; 92(6):1438-45. PubMed ID: 15583754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of endothelial progenitor cells in tumor angiogenesis.
    Ribatti D
    J Cell Mol Med; 2004; 8(3):294-300. PubMed ID: 15491505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium.
    Göthert JR; Gustin SE; van Eekelen JA; Schmidt U; Hall MA; Jane SM; Green AR; Göttgens B; Izon DJ; Begley CG
    Blood; 2004 Sep; 104(6):1769-77. PubMed ID: 15187022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature.
    Reddy K; Cao Y; Zhou Z; Yu L; Jia SF; Kleinerman ES
    Angiogenesis; 2008; 11(3):257-67. PubMed ID: 18344025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.
    Lyden D; Hattori K; Dias S; Costa C; Blaikie P; Butros L; Chadburn A; Heissig B; Marks W; Witte L; Wu Y; Hicklin D; Zhu Z; Hackett NR; Crystal RG; Moore MA; Hajjar KA; Manova K; Benezra R; Rafii S
    Nat Med; 2001 Nov; 7(11):1194-201. PubMed ID: 11689883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
    Huang S; He P; Peng X; Li J; Xu D; Tang Y
    Cell Physiol Biochem; 2015; 37(1):253-68. PubMed ID: 26302893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
    Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.
    Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA
    Cancer Res; 2006 Sep; 66(18):9054-64. PubMed ID: 16982747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic vascular endothelial growth factor regulates recruitment of rat liver sinusoidal endothelial cell progenitor cells.
    Wang L; Wang X; Wang L; Chiu JD; van de Ven G; Gaarde WA; Deleve LD
    Gastroenterology; 2012 Dec; 143(6):1555-1563.e2. PubMed ID: 22902870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of bone marrow beta3-integrin enhances non-functional neovascularization.
    Watson AR; Pitchford SC; Reynolds LE; Direkze N; Brittan M; Alison MR; Rankin S; Wright NA; Hodivala-Dilke KM
    J Pathol; 2010 Mar; 220(4):435-45. PubMed ID: 19967726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
    Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
    Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
    Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
    Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.